Glaucoma plugs could stop the need for drops

Glaucoma plugs could stop the need for drops

Posted on 08th September 2012

A trial of a new method of delivering glaucoma medication by using a slow release punctum plug has started.

Glaucoma usually requires patients to permanently take drops once or twice a day to reduce pressure inside the eye. Patients often find it difficult to remember to take the drops or hard to get them int the eye and methods which overcome these issues would be very useful.

After an initial small trial in Singapore showed promise, this longer South African trial uses a punctum plug containing the popular glaucoma medication travoprost (Travatan) which is taken in drop form once a day. The plugs will be trialled over a period of 2 months with pressure being monitored regularly for any signs of change.

Punctum plugs are normally used for helping treat dry eye by blocking the tear ducts


Related Posts

Eyewear boutique summer event

23rd June 2017

Last night we held our summer frame preview event in our independent eyewear boutique. Thank you to all who attended. We loved seeing so many guests experimenting with different styles and looking utt...

Read more

We’ve been shortlisted for another award

09th June 2017

We're thrilled to learn Ian Cameron has been shortlisted for the BCLA's (British Contact Lens Association) Dry Eye Award. For those who have experienced dry eye (ocular surface disease), you will know...

Read more

Cameron Optometry represented at conference for international contact lens specialists

08th June 2017

Former managing director and founder of Cameron Optometry, Donald Cameron, attended the International Society of Contact Lens Specialists (ISCLS), along with Ian Cameron. Here Donald shares some of th...

Read more

Practice manager Carol completes the Edinburgh Marathon (by accident!)

29th May 2017

For patients of the practice, you will know Carol Field, our dispensing practice manager. On Sunday Carol did something amazing. Carol completed the Edinburgh Marathon. The reason this is a particula...

Read more